Avtar Roopra’s research has effectively stalled since President Donald Trump started his second term and upended the federal research funding landscape. Agencies have cut projects, delayed grant reviews, fired thousands of federal employees who offer guidance to researchers and reduced the number of new projects getting funding.
“This is like the Holy Grail of epilepsy, what we’ve been looking for for hundreds of years,” Roopra said. “All of it is on hold. It’s extremely frustrating.”